about
Sitosterolemia: diagnosis, investigation, and management.The spinal cord expression of neuronal and inducible nitric oxide synthases and their contribution in the maintenance of neuropathic pain in mice.Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 gene.The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioidsApolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility.Molecular characterization of the breakpoints of an inversion fixed between Drosophila melanogaster and D. subobscura.Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling.Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation.The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic miceAutosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical settingA rare STAP1 mutation incompletely associated with familial hypercholesterolemiaHuman ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in MiceApolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotypeIdentification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutationMolecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients
P50
Q33415263-EC86E1DA-E2EB-4B7F-ACEF-7177F80DD46BQ33778231-65DD7C4E-AF17-4AF6-A7BD-5A54BA9BF2FDQ33807020-DE2252CB-1757-427D-AB1E-6968487EDFF2Q34059667-E7585493-3282-4FC5-8818-C09C7E312F6AQ35786184-4A10F431-7049-4D09-A18A-FF8423A3D74DQ36698911-8E278D04-60BA-49A0-AD54-A0C29A68AC81Q36744086-C5DE916B-A652-4C0D-B3F5-EAAB7869F9DBQ38730033-3D3D8546-F943-40DE-9942-7D8DBB56E4E4Q39141274-8BCB7698-C0FB-4D03-A5F7-1431622A9327Q42120200-F0F45C41-3687-49E6-AA89-515DE4325386Q44200531-33717FBE-B3D6-4357-BBF5-092AA3A669C7Q44346644-3AC7B6F7-BC27-4F57-BD82-7004AA415AA1Q44890794-D5977772-C040-4F77-A045-C6466ED48526Q45858580-C5DA7CAF-A607-4DC6-B489-1BDAFFF94C0BQ46580809-1F9850F5-21D7-4142-B2B7-08FC19947BF9Q57031178-CED2A5E8-994C-4CD0-BD74-D1D97EAA1D8FQ57192292-673BDFE6-F399-416E-98F0-E59B8912E60FQ57293855-2175A39E-1712-4016-9DAD-567697AEAB73Q64277669-E7C8A43E-7910-414B-B5C6-CCF2423546DAQ80335822-E5DAFF53-62C3-4612-A62B-0A26CCF54315Q82879310-3A13EF90-358F-4350-B416-C9C930C83784Q91723022-1FD28455-B535-404C-B40D-60B52C2E2688
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jesús M Martín-Campos
@ast
Jesús M Martín-Campos
@en
Jesús M Martín-Campos
@es
Jesús M Martín-Campos
@nl
Jesús M Martín-Campos
@sl
type
label
Jesús M Martín-Campos
@ast
Jesús M Martín-Campos
@en
Jesús M Martín-Campos
@es
Jesús M Martín-Campos
@nl
Jesús M Martín-Campos
@sl
prefLabel
Jesús M Martín-Campos
@ast
Jesús M Martín-Campos
@en
Jesús M Martín-Campos
@es
Jesús M Martín-Campos
@nl
Jesús M Martín-Campos
@sl
P106
P1153
6602504166
P31
P496
0000-0003-0414-037X